FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2025
Voltar para busca
Dado oficial do USPTO
NT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
01/03/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
15/10/2021
Data de registro
20/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/08/2024
Última transação
01/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
AU
Examinador
KEATING, MICHAEL
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized letters NT in white against a dark green background.
Titulares e representantes
Titulares
Novotech (Australia) Pty Ltd
Representantes
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
conducting clinical trials for others; scientific research in the nature of conducting and managing clinical trials for othersincluding clinical trials for pharmaceuticalsbiotechnology and other related industries; scientific research in the nature of conducting clinical trials for others; providing information about the results of clinical trials conducted for othersincluding clinical trials for pharmaceuticals and biotechnology; scientific research; scientific research for medical purposes; providing information in the field of scientific research result statistics; providing information in the field of scientific research result biostatistics in the fields of pharmaceuticalsbiotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials conducted for others; medical research servicesmedical monitoring of clinical trials for others for research purposes in the fields of pharmaceuticalsbiotechnology and other related industries; quality control audits; scientific researchpreparation of reports and applications to regulators relating to scientific research aspects of clinical trials; providing a website featuring technology allowing the provision and exchange of information and data exchange between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/02/2025
FIMP
FINAL DISPOSITION PROCESSED
05/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
20/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/06/2024
PUBO
PUBLISHED FOR OPPOSITION
04/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
17/04/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
17/10/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/04/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
19/04/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/04/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/10/2022
GNSL
LETTER OF SUSPENSION E-MAILED
20/10/2022
CNSL
SUSPENSION LETTER WRITTEN
20/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/10/2022
RFNT
REFUSAL PROCESSED BY IB
12/09/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/08/2022
RFRR
REFUSAL PROCESSED BY MPU
19/08/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/07/2022
CNRT
NON-FINAL ACTION WRITTEN
26/07/2022
DOCK
ASSIGNED TO EXAMINER
22/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
23/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/11/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/11/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.